A
$ Value
$0
Shares
670
Price
$0
Filed
Apr 21
Insider
Name
Epperly Melissa B,
Title
—
CIK
0001807359
Roles
Director
Transaction Details
Transaction Date
2026-04-17
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
16,474
Footnotes
Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.
Filing Info
Other Insiders at ROIV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MOMTAZEE JAMES C | — | — | 2026-04-17 |
| Fitzgerald Meghan | — | $1.9M | 2026-03-26 |
| Oren Ilan | — | — | 2026-04-17 |
|
Torti Frank
President and Vant Chair
|
— | — | 2026-03-31 |
|
Sukhatme Mayukh
President & CIO
|
— | — | 2026-03-31 |
|
Gline Matthew
CEO
|
— | $8.4M | 2026-04-16 |
|
Venker Eric
President & Immunovant CEO
|
— | $5.9M | 2026-04-20 |
|
Pulik Richard
CFO
|
— | — | 2026-04-20 |
|
Humes Jennifer
Chief Accounting Officer
|
— | $384K | 2026-04-20 |